Health Care Providers’ Experiences With and Perceived Barriers to Implementation of Long-Acting Injectable HIV Preexposure Prophylaxis: A Cross-Sectional Survey
Journal of the International Association of Providers of AIDS Care (JIAPAC) · 2026
DOI: 10.1177/23259582261471981 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of the International Association of Providers of AIDS Care (JIAPAC), 2026. Verfasst von Elena Beideck und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. Hauptthemen laut MEDLINE: HIV Infections, Health Personnel, Pre-Exposure Prophylaxis, Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, Harvard University Center for AIDS Research, NIH.
Abstract (Originalsprache)
Introduction
Long-acting injectable cabotegravir (CAB-LA) is highly efficacious as PrEP and could increase PrEP coverage, though uptake has been limited.
Methods
We surveyed healthcare professionals regarding experiences with CAB-LA implementation in the United States. We used descriptive statistics to summarize perceived barriers and Fisher’s exact tests to assess for factors associated with CAB-LA availability and use.
Results
Among respondents, 71% (51/72) reported their clinic site offered CAB-LA though only 44% (20/45) reported having prescribed it. The most common perceived barriers were concerns about insurance coverage (38/45, 84%), logistics (35/45, 78%), lack of requests (32/45, 71%), concern for missed injections (17/25, 68%), and cost (16/25, 64%). A majority (30/45, 67%) felt that lack of training was a barrier. Availability and prescribing did not vary by demographic or patient panel characteristics (p-values>0.05).
Conclusions
Healthcare professionals’ perceived barriers to CAB-LA uptake suggest need for improved implementation strategies, specifically surrounding cost, logistics, and education.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- The Fenway Institute, Fenway Health, Boston, MA, USA.
- Department of Population Medicine, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Elena Beideck
Förderung
- NIAID NIH HHS
- Harvard University Center for AIDS Research
- NIH
Zitieren
APA
Beideck, E., Gould, R., & Krakower, D. (2026). Health Care Providers’ Experiences With and Perceived Barriers to Implementation of Long-Acting Injectable HIV Preexposure Prophylaxis: A Cross-Sectional Survey. Journal of the International Association of Providers of AIDS Care (JIAPAC). https://doi.org/10.1177/23259582261471981
Vancouver
Beideck E, Gould R, Krakower D. Health Care Providers’ Experiences With and Perceived Barriers to Implementation of Long-Acting Injectable HIV Preexposure Prophylaxis: A Cross-Sectional Survey. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2026. doi:10.1177/23259582261471981
BibTeX
@article{Beideck2026,
author = {Beideck, Elena and Gould, Ryan and Krakower, Douglas},
title = {Health Care Providers’ Experiences With and Perceived Barriers to Implementation of Long-Acting Injectable HIV Preexposure Prophylaxis: A Cross-Sectional Survey},
journal = {Journal of the International Association of Providers of AIDS Care (JIAPAC)},
year = {2026},
doi = {10.1177/23259582261471981}
}
EUVIMED